OTHER
Norwegian Capture the Fracture Initiative
Status
Completed
Phase
Not applicable
Enrollment
94,260
Locations
7
Results
Not posted
Publications
1
Study summary
What the protocol is testing.
The main aim is to assess the effectiveness of introducing a standardized intervention program for treatment of patients with a fragility fracture as measured by changes in the fracture rates and the mortality.
Full detailed description
A fracture liaison service model of care is widely recommended but data on its effectiveness regarding reduced risk of recurrent fracture and fracture related mortality are scarce. The investigators therefore aim to assess the risk of subsequent fractures and mortality after a clinical fracture in patients who present to hospitals with a standardized intervention program. Seven Norwegian hospitals will be Stepped Wedge Cluster Randomized to a standardized intervention program with startup date between May 2015 and Jan 2016. The intervention will last throughout 2018 with follow-up throughout 2019. Outcomes before and after the intervention will be compared and each hospital will act as its own control. The effect of the intervention will be measured by using national patient registries on fractures and mortality.
Interventions
Treatment arms and agents.
OTHER
Current treatment
Timeline
From registration to results.
First posted
Sep 1, 2015
Study start
May 2015
Primary completion
Jan 2020
Study completion
May 2020
Results posted
Not reported
Registry updated
Mar 22, 2022
Outcomes
What the study measures.
Primary outcomes
Fragility fracture
Time frame · 4 years
Incidence of fragility fractures per 10,000 person-years (distal forearm fractures, proximal humerus fractures and hip fractures)
Secondary outcomes
Mortality
Time frame · 4 years
Total number of deaths during four years after enrollment
Eligibility
Who can take part.
- Minimum age
- 50 Years
- Maximum age
- Not reported
- Sex
- ALL
- Healthy volunteers
- No
Inclusion Criteria: * Low-energy fracture Exclusion Criteria: * finger fracture, toe fracture, face fracture, skull fracture
Study locations
7 registered sites.
Norway. Showing up to 24 locations stored in the fast local snapshot.
Haukeland University Hospital
Bergen, Norway
Drammen Hospital
Drammen, Norway
Molde Hospital
Molde, Norway
Oslo University Hospital
Oslo, Norway
Bærum Hospital
Sandvika, Norway
University Hospital of North Norway
Tromsø, Norway
St. Olavs University Hospital
Trondheim, Norway
Related trials
More studies on Teriparatide.
Sequential Therapies After Osteoanabolic Treatment
424 General Military Hospital · Osteoporosis, Postmenopausal
Not applicable
Recruiting
150
2026-07
A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants
Syneos Health · Healthy Volunteers
Phase 1
Recruiting
48
2026-07
Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid
University of Edinburgh · Osteogenesis Imperfecta
Phase 4
Completed
350
2026-06
Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action
Sheffield Teaching Hospitals NHS Foundation Trust · Osteoporosis
Phase 4
Completed
19
2026-05
Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery
The University of Hong Kong · Osteoporosis · Fusion of Spine, Lumbar Region
Not applicable
Active, not recruiting
192
2026-05
Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
Madhumathi Rao · Age-Related Osteoporosis
Phase 4
Active, not recruiting
60
2026-05
A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens
Shenzhen Salubris Pharmaceuticals Co., Ltd. · Postmenopausal Women With Osteoporosis
Phase 2
Recruiting
200
2026-05
Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis
University Health Network, Toronto · Osteoporosis
Not applicable
Active, not recruiting
100
2026-05
Related PeptideStat pages
Put the record in context.
Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.